Condition (MeSH)
Septo-Optic Dysplasia
ClinicalTrials.gov lists 5 trials for Septo-Optic Dysplasia or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Septo-Optic Dysplasia itself; the rest are tagged with a narrower condition beneath it.
When did Septo-Optic Dysplasia trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2023 | 1 |
| 2020 | 1 |
| 2008 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Septo-Optic Dysplasia trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 1 |
How many Septo-Optic Dysplasia trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 3 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Septo-Optic Dysplasia trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Gaziosmanpasa Research and Education Hospital | 1 |
| Rhythm Pharmaceuticals, Inc. | 1 |
Which publications cover Septo-Optic Dysplasia? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study. | BMJ open | 2025 | Yes |
| Novel molecular mechanism in Malan syndrome uncovered through genome sequencing reanalysis, exon-level Array, and RNA sequencing. | American journal of medical genetics. Part A | 2024 | Yes |
| Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. | The Journal of clinical endocrinology and metabolism | 2012 | Yes |
| Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study. | Hormone research in paediatrics | 2013 | No |
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Septo-optic dysplasia spectrum | Prevalence at birth | 1-5 / 10 000 | Europe | Not stated | Unspecified |
| Septo-optic dysplasia spectrum | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Septo-optic dysplasia spectrum | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Septo-optic dysplasia spectrum | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Septo-optic dysplasia spectrum | Prevalence at birth | 1-5 / 10 000 | Europe | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Septo-optic dysplasia spectrum | 3157 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Septo-optic dysplasia spectrum | 3157 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.